medigraphic.com
ISSN 0210-5187 (Electronic)

2013, Number 5

<< Back Next >>

Med Cutan Iber Lat Am 2013; 41 (5)

Frontal fibrosing alopecia and lichen planopilaris: are statins a pathogenic factor?

González-Rodríguez AJ, Gutiérrez-Paredes EM, Bella-Navarro R, Pellicer-Oliver ZM, Montesinos-Villaescusa E, Martín-Hernández JM, Jordá-Cuevas E

Language: Spanish
References: 26
Page: 210-217
PDF size: 677.57 Kb.


ABSTRACT

Background: Frontal fibrosing alopecia (FFA) is characterized by the recession of the frontotemporal hair line constituting a rare form of scarring alopecia that predominantly affects postmenopausal women. Is currently considered a variant of lichen planopilaris (LPP).
Objective: To determine the possible statistical association between taking statins and the development of FFA/LPP.
Material and methods: A case-control study unpaired was undertaken in the Department of Dermatology at Hospital Clínico Universitario in Valencia (Spain) during a period of 7 years between February 2004 and December 2010 and included 20 patients diagnosed with FFA/LPP along with 22 controls.
Results: Of the 20 cases reported, 15 were on statin therapy, having been introduced prior to the development of alopecia in 12 of them. In 12 patients, diagnosis was confirmed histologically. We have seen the stabilization of the disease on drug withdrawal. By statistical analysis was obtained an odds ratio of 2,16 with a confidence interval of 95% (1,58-7,44).
Conclusions: According to data from our study and considering its limitations, taking a statin could doubles the risk of developing FFA/LPP, although more studies are needed to support this hypothesis.


REFERENCES

  1. Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130: 770-4. Erratum in: Arch Dermatol 1994; 130: 1407.

  2. Chew AL, Bashir SJ, Wain EM, Fenton DA, Stefanato CM. Expanding the spectrum of frontal fibrosing alopecia: A unifying concept. J Am Acad Dermatol 2010; 63: 653- 60.

  3. Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a variant of lichen planopilaris. J Am Acad Dermatol 1997; 36: 59-66.

  4. Escalonilla P, Soriano ML, Grillo R, Fariña C, Martín L, Requena L, et al. Alopecia frontal fibrosante postmenopáusica: una variante de liquen plano folicular de localización peculiar. Actas Dermosifiliogr 1999; 90: 185-95.

  5. Moreno-Ramírez D, Camacho-Martínez F. Frontal fibrosing alopecia: a survey in 16 patiens. J Eur Acad Dermatol Venereol 2005; 19: 700-5.

  6. Abal-Díaz L, Soria X, Casanova-Seuma JM. Alopecias cicatriciales. Actas Dermosifiliogr 2012; 103: 376-87.

  7. Moreno-Ramírez D, Ferrándiz L, Camacho FM. Alopecia frontal fibrosante. Valoración diagnóstica y terapéutica. Actas Dermosifiliogr 2007; 98: 594-602.

  8. Poblet E, Jiménez F, Pascual A, Piqué E. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol 2006; 45: 375-80.

  9. Inui S, Nakajima T, Shono F, Itami S. Dermoscopic findings in frontal fibrosing alopecia: report of four cases. Int J Dermatol 2008; 47: 796-9.

  10. Mireles-Rocha H, Sánchez-Dueñas LE, Hernández- Torres M. Alopecia frontal fibrosante. Hallazgos dermatoscópicos. Actas Dermosifiliogr 2012; 103: 167-8.

  11. Dawn G, Holmes SC, Moffat D, Munro CS. Post-menopausal frontal fibrosing alopecia. Clin Exp Dermatol 2003; 28: 43-5.

  12. Tan KT, Messenger AG. Frontal fibrosing alopecia: clinical presentations and prognosis. Br J Dermatol 2009; 160: 75-9.

  13. Smidarle DN, Seidl M, Silva RC. Frontal fibrosing alopecia: case report. An Bras Dermatol 2010; 85: 879-82.

  14. Gómez J, Martínez J, Babín F, Montoya T, Espejo J. A working-day evaluation of dyslipidaemia in a Spanish Population (JADE study). Clin Drug Invest 2000; 19: 131-42.

  15. Gómez-Belda A, Rodilla E, Albert A, García L, González C, Pascual JM. Clinical use of statins and cholesterol goals in patients with several cardiovascular risk factors. Med Clin (Barc) 2003; 121: 527-31.

  16. Arias-Santiago S, Gutiérrez-Salmerón MT, Buendía-Eisman A, Girón-Prieto MS, Naranjo- Sintes R. A comparative study of dyslipidaemia in men and woman with androgenic alopecia. Acta Derm Venereol 2010; 90: 485-7.

  17. Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T, Javier Félix F, Zorrilla B, Rigo F, Lapetra J, Gavrila D, Segura A, Sanz H, Fernández-Bergés D, Fitó M, Marrugat J. Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study. Rev Esp Cardiol 2011; 64: 295-304.

  18. Vegazo O, Banegas JR, Civeira F, Serrano Aisa PL, Jiménez FJ, Luengo E. Prevalence of dyslipidemia in outpatients of the Spanish health ser-vice: the HISPALIPID Study. Med Clin (Barc) 2006; 127: 331-4.

  19. Gómez-Belda A, Rodilla E, González C, Costa JA, Serra B, Pascual JM. Lipid lowering goals in high risk and very high cardiovascular risk patients: a reasonable challenge? Rev Clin Esp 2006; 206: 417- 21.

  20. Segal AS. Alopecia associated with atorvastatin. Am J Med 2002; 113: 171.

  21. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol 1993; 29: 249-55.

  22. Stoebner PE, Michot C, Ligeron C, Durand L, Meynadier J, Meunier L. Simvastatininduced lichen planus pemphigoides. Ann Dermatol Venereol 2003; 130 (2 Pt 1): 187-90.

  23. Roger D, Rolle F, Labrousse F, Brosetti A, Bonnetblanc JM. Simvastatin-induced lichenoid drug eruption. Clin Exp Dermatol 1994; 19: 88-9.

  24. Keough GC, Richardson TT, Grabski WJ. Pravastatin-induced lichenoid drug eruption. Cutis 2000; 61: 98-100.

  25. Sebök B, Tóth M, Anga B, Harangi F, Schneider I. Lichenoid drug eruption with HMGCoA reductase inhibitors (fluvastatin and lovastatin). Acta Derm Venereol 2004; 84: 229-30.

  26. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Alopecia androgénica masculina y factores de riesgo cardiovascular: estudio de casos y controles. Actas Dermosifiliog 2010; 101: 248-56.




2020     |     www.medigraphic.com